Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

被引:0
作者
Carmen Balaña
Antonio López-pousa
Alfonso Berrocal
Ricardo Yaya-tur
Ana Herrero
Jose-luis García
Javier Martín-broto
Manuel Benavides
Miguel Cerdá-nicolás
Rosa Ballester
Josep Balart
Jaume Capellades
机构
[1] Hospital Universitari Germans Trias i Pujol,Medical Oncology Services, Institut Catala d’Oncologia
[2] Hospital Santa Creu i Sant Pau,Medical Oncology Services
[3] Hospital General de Valencia,Medical Oncology Services
[4] Instituto Valenciano de Oncología,Medical Oncology Services
[5] Hospital Universitario Miguel Servet,Medical Oncology Services
[6] Hospital Ramón y Cajal,Medical Oncology Services
[7] Hospital Son Dureta,Medical Oncology Services
[8] Hospital Regional Carlos Haya,Medical Oncology Services
[9] Hospital Clínico Universitario,Pathology Central Review,Departamento de Patologia, Neuropatologia
[10] Institut Catala d’ Oncologia,Oncology
[11] Hospital Universitari Germans Trias i Pujol,Radiotherapy Services
[12] Hospital Santa Creu i Sant Pau,Oncology
[13] Hospital Universitari Germans Trias i Pujol,Radiotherapy Services
来源
Journal of Neuro-Oncology | 2004年 / 70卷
关键词
cisplatin; chemotherapy; glioblastoma; pre-radiotherapy; temozolomide;
D O I
暂无
中图分类号
学科分类号
摘要
This phase II study evaluates the activity of temozolomide and cisplatin administered before radiation therapy in newly diagnosed glioblastoma multiforme patients, in terms of response, time to progression and survival.
引用
收藏
页码:359 / 370
页数:11
相关论文
共 283 条
[1]  
Davis FG(1998)Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991 J Neurosurg 88 1-10
[2]  
Freels S(2002)Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 1011-1018
[3]  
Grutsch J(1993)Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704-710
[4]  
Barlas S(2000)A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83 588-593
[5]  
Brem S(2001)Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12 259-266
[6]  
Afra D(1998)DNA Mismatch repair and O J Clin Oncol 16 3851-3857
[7]  
Baron B(2002)-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma Neuro-Oncology 4 261-267
[8]  
Bonadonna G(2000)A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy Mutation Research/Reviews in Mutation Research 462 83-100
[9]  
Burdett S(1996)Repair of O J Pharmacol Exp Ther 279 416-422
[10]  
Parmer MKB(1996)-alkylguanine by alkyltransferases Br J Cancer 73 482-490